Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years

Jaya Goswami, Jose F Cardona, Jorge Caso, Denise C Hsu, Alana K Simorellis, Lauren Wilson, Rakesh Dhar, Xiaowei Wang, Archana Kapoor, Avi Collins, Vinicius Righi, Lan Lan, Jiejun Du, Honghong Zhou, Sonia K Stoszek, Christine A Shaw, Caroline Reuter, Eleanor Wilson, Rituparna Das

Open source

DOI: 10.1093/cid/ciaf515
Published: 2025-09-24
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciaf515,
  title = {Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years},
  author = {Jaya Goswami and Jose F Cardona and Jorge Caso and Denise C Hsu and Alana K Simorellis and Lauren Wilson and Rakesh Dhar and Xiaowei Wang and Archana Kapoor and Avi Collins and Vinicius Righi and Lan Lan and Jiejun Du and Honghong Zhou and Sonia K Stoszek and Christine A Shaw and Caroline Reuter and Eleanor Wilson and Rituparna Das},
  year = {2025},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciaf515},
  url = {https://doi.org/10.1093/cid/ciaf515}
}

RIS

TY  - JOUR
TI  - Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years
AU  - Jaya Goswami
AU  - Jose F Cardona
AU  - Jorge Caso
AU  - Denise C Hsu
AU  - Alana K Simorellis
AU  - Lauren Wilson
AU  - Rakesh Dhar
AU  - Xiaowei Wang
AU  - Archana Kapoor
AU  - Avi Collins
AU  - Vinicius Righi
AU  - Lan Lan
AU  - Jiejun Du
AU  - Honghong Zhou
AU  - Sonia K Stoszek
AU  - Christine A Shaw
AU  - Caroline Reuter
AU  - Eleanor Wilson
AU  - Rituparna Das
PY  - 2025
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciaf515
UR  - https://doi.org/10.1093/cid/ciaf515
ER  -

APA

Goswami, J., Cardona, J. F., Caso, J., Hsu, D. C., Simorellis, A. K., Wilson, L., Dhar, R., Wang, X., Kapoor, A., Collins, A., Righi, V., Lan, L., Du, J., Zhou, H., Stoszek, S. K., Shaw, C. A., Reuter, C., Wilson, E., & Das, R. (2025). Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf515

Source records

crossref · retrieved 2026-09-25T22:31:46.814Z